跳至主要内容
临床试验/JPRN-UMIN000010724
JPRN-UMIN000010724招募中未知

A Phase II Study of TS-1 + CDDP + Lentinan combination chemotherapy for unresectable or recurrent gastric cancer - A Phase II Study of TS-1 + CDDP + Lentinan in advanced gastric cancer

Jichi Medical University0 个研究点目标入组 35 人开始时间: 2013年5月15日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who are contraindicated to S-1, CDDP, and Lentinan. 2. Patients with active infection. 3. Patient with a previous history of congestive heart failure. 4. Serious complication as followings ; a. Short bowel obstruction b. Interstitial pneumonia, Pulmonary fibrosis c. Uncontrolled diabetes mellitus d. Renal failure e. Hepatic failure 5. Patients with massive ascites or pleural effusion. 6. Patient with bone metastasis. 7. Patient with brain metastases or previous history of brain metastasis. 8. Patients with fresh bleeding from gastric cancer and/or the digestive tract. 9. Patients with diarrhea (4 or more times per day or watery diarrhea). 10. Patients who take psychotropic drug. 11. Patients with second primary malignancy. 12. Women in pregnancy, at risk of pregnancy, hoping to become pregnant. 13. Men who want their partners to become pregnant. 14. Any patients judged by the investigator to be unfit to participate in the study.

研究者

相似试验